Live Breaking News & Updates on One Bio

Stay updated with breaking news from One bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

One Bio CEO on going back to nature to pioneer next-generation nutrients

One Bio entered the market last month on a mission to end inflammatory disease and decimate food waste by making odorless, colorless and tasteless fiber from salvaged agricultural byproducts. ....

Carlito Lebrilla , David Mills , Matt Barnard , Matt Amicucci , One Bio , Bio Co Founder , Bruce German , Ut Digestive Health , Healthy Aging , Fibers Amp Carbohydrates , Icrobiome Modulation , Food System , Startup Company ,

Hengrui inks $1B out-licensing deal for asthma drug with One Bio

With a U.S. biotech identified as One Bio, Jiangsu Hengrui Pharmaceutical Co. Ltd. has inked an out-licensing deal potentially worth $1.05 billion for its asthma and chronic sinusitis-targeting drug, SHR-1905. The latest deal gives One Bio exclusive rights to develop, produce and commercialize SHR-1905 worldwide, excluding the greater China territory. ....

Jiangsu Hengrui Pharmaceutical Co , One Bio , Jiangsu Hengrui Pharmaceutical , Jiangsu Hengrui Pharmaceutical Co Ltd , Shr 1905 , Gyroscope Therapeutics Ltd , Monoclonal Antibody , Thymic Stromal Lymphopoietin ,

Hengrui inks $1B out-licensing deal for asthma drug with One Bio

With a U.S. biotech identified as One Bio, Jiangsu Hengrui Pharmaceutical Co. Ltd. has inked an out-licensing deal potentially worth $1.05 billion for its asthma and chronic sinusitis-targeting drug, SHR-1905. The latest deal gives One Bio exclusive rights to develop, produce and commercialize SHR-1905 worldwide, excluding the greater China territory. ....

Jiangsu Hengrui Pharmaceutical Co , One Bio , Jiangsu Hengrui Pharmaceutical , Jiangsu Hengrui Pharmaceutical Co Ltd , Shr 1905 , Gyroscope Therapeutics Ltd , Monoclonal Antibody , Thymic Stromal Lymphopoietin ,